CSTL EBITDA Growth
Castle Biosciences Inc · EBITDA Growth
CSTL EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-109.94%period ending
CSTL TTM EBITDA YoY % (373.24% → -109.94%)
Year-over-year change
High-resolution chart · PNG
CSTL ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -109.9352% | |
| -106.1717% | |
| -70.258% | |
| -4.2946% | |
| 248.0923% | |
| 328.2844% | |
| 184.7059% | |
| 139.5396% | |
| 112.1444% | |
| 71.3256% | |
| 22.8301% | |
| -16.7381% | |
| -61.4822% | |
| -13.5011% | |
| -59.3924% | |
| -100.1068% | |
| -136.0511% | |
| -336.8295% | |
| -415.9853% | |
| -18,423.4802% | |
| -284.7518% | |
| -205.0962% | |
| -169.0212% | |
| -98.754% | |
| 429.5501% | |
| 1,302.008% | |
| 373.2399% |